Adam Blank
Adult Medicine · San Luis Obispo, CANPI 1710564919
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AstraZeneca at 24.0% of the total.
Across 124 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$625
- GSK$312
- Amgen$246
- AbbVie$198
- Novo Nordisk$182
- Lilly USA, LLC$142
- plus $897 from 17 others
What the payments were for
- Food & beverage$2,602100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 31 | $625 |
| GSK | 15 | $312 |
| Amgen | 13 | $246 |
| AbbVie | 10 | $198 |
| Novo Nordisk | 9 | $182 |
| Lilly USA, LLC | 5 | $142 |
| Bayer | 7 | $136 |
| Sumitomo Pharma America, Inc. | 5 | $122 |
| Pfizer | 4 | $88 |
| Vertex | 3 | $84 |
| Exact Sciences | 4 | $78 |
| Novartis | 2 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Abiomed | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Boehringer Ingelheim | 1 | $28 |
| Edwards Lifesciences | 1 | $26 |
| Agios Pharmaceuticals, Inc. | 1 | $22 |
| Ascensia Diabetes Care US Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
How this compares
$2,602 in reported general payments places this provider in the 85th percentile of 221 adult medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 36 | $35,246 |
| JardianceEmpagliflozin | 11 | $13,697 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $9,305 |
| BreynaBudesonide/Formoterol Fumarate | 11 | $781 |
| Rosuvastatin Calcium | 40 | $374 |
| Metoprolol Succinate | 15 | $280 |
| Losartan Potassium | 30 | $265 |
| Atorvastatin Calcium | 41 | $257 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $255 |
| Gabapentin | 19 | $216 |
| Tamsulosin Hcl | 27 | $189 |
| Olmesartan Medoxomil | 15 | $168 |
| Amlodipine Besylate | 32 | $134 |
| Metformin Hcl | 18 | $123 |
| Lisinopril | 30 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $182 | $35,24636 claims |
| Boehringer IngelheimJardiance | $28 | $13,69711 claims |
| GSKTrelegy Ellipta | $312 | $9,30515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 221 adult medicine providers in California.
Other adult medicine in San Luis Obispo
- Soquel SchaferSan Luis Obispo$3K
- Susan HutchinsonLaguna Hills$1M
- Natalia GuzmanLos Angeles$583K
- Richard FauselRancho Mirage$30K
- Benedicto EstoestaValley Springs$22K
- Antoine DipsiaW. Sacramento$21K
- Patrick WelchArroyo Grande$20K
- Craig BobsonManteca$19K
- Tin WongLos Angeles$18K
- Sofia VaismanWoodland Hills$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.